Brief: Oramed Granted Key European Patent For Platform Technology In Oral Delivery Of Proteins
05/01/2022 12:49
Jan 5 (Reuters) - Oramed Pharmaceuticals Inc ORMP.O :
* ORAMED GRANTED KEY EUROPEAN PATENT FOR PLATFORM TECHNOLOGY
IN
ORAL DELIVERY OF PROTEINS
Source text for Eikon: ID:nPn4RNJ2ya
Further company coverage: ORMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results